Literature DB >> 24565867

A piggyBac insertion disrupts Foxl2 expression that mimics BPES syndrome in mice.

Fubiao Shi1, Sheng Ding2, Shimin Zhao1, Min Han3, Yuan Zhuang4, Tian Xu2, Xiaohui Wu5.   

Abstract

Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is an autosomal dominant genetic disorder characterized by small palpebral fissures and other craniofacial malformations, often with (type I) but could also without (type II) premature ovarian failure. While mutations of the forkhead transcription factor FOXL2 are associated with and likely be responsible for many BPES cases, how FOXL2 affects craniofacial development remain to be understood. Through a large-scale piggyBac (PB) insertion mutagenesis, we have identified a mouse mutant carrying a PB insertion ∼160 kb upstream of the transcription start site (TSS) of Foxl2. The insertion reduces, but not eliminates, the expression of Foxl2. This mutant, but not its revertant, displays BPES-like conditions such as midface hypoplasia, eyelid abnormalities and female subfertility. Further analysis indicates that the mutation does not affect mandible, but causes premature fusion of the premaxilla-maxilla suture, smaller premaxilla and malformed maxilla during midface development. We further identified an evolutionarily conserved fragment near the insertion site and observed enhancer activity of this element in tissue culture cells. Analyses using DNase I hypersensitivity assay and chromosome conformation capture assay in developing maxillary and periocular tissues suggest that the DNA region near the insertion site likely interacts with Foxl2 TSS. Therefore, this mutant presents an excellent animal model for mechanistic study of BPES and regulation of Foxl2.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24565867     DOI: 10.1093/hmg/ddu092

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  4 in total

1.  Novel action of FOXL2 as mediator of Col1a2 gene autoregulation.

Authors:  Mara Marongiu; Manila Deiana; Loredana Marcia; Andrea Sbardellati; Isadora Asunis; Alessandra Meloni; Andrea Angius; Roberto Cusano; Angela Loi; Francesca Crobu; Giorgio Fotia; Francesco Cucca; David Schlessinger; Laura Crisponi
Journal:  Dev Biol       Date:  2016-05-19       Impact factor: 3.582

2.  FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice.

Authors:  Mara Marongiu; Loredana Marcia; Emanuele Pelosi; Mario Lovicu; Manila Deiana; Yonqing Zhang; Alessandro Puddu; Angela Loi; Manuela Uda; Antonino Forabosco; David Schlessinger; Laura Crisponi
Journal:  BMC Dev Biol       Date:  2015-07-02       Impact factor: 1.978

3.  A genome-wide association scan in admixed Latin Americans identifies loci influencing facial and scalp hair features.

Authors:  Kaustubh Adhikari; Tania Fontanil; Santiago Cal; Javier Mendoza-Revilla; Macarena Fuentes-Guajardo; Juan-Camilo Chacón-Duque; Farah Al-Saadi; Jeanette A Johansson; Mirsha Quinto-Sanchez; Victor Acuña-Alonzo; Claudia Jaramillo; William Arias; Rodrigo Barquera Lozano; Gastón Macín Pérez; Jorge Gómez-Valdés; Hugo Villamil-Ramírez; Tábita Hunemeier; Virginia Ramallo; Caio C Silva de Cerqueira; Malena Hurtado; Valeria Villegas; Vanessa Granja; Carla Gallo; Giovanni Poletti; Lavinia Schuler-Faccini; Francisco M Salzano; Maria-Cátira Bortolini; Samuel Canizales-Quinteros; Francisco Rothhammer; Gabriel Bedoya; Rolando Gonzalez-José; Denis Headon; Carlos López-Otín; Desmond J Tobin; David Balding; Andrés Ruiz-Linares
Journal:  Nat Commun       Date:  2016-03-01       Impact factor: 14.919

4.  Mapping of Craniofacial Traits in Outbred Mice Identifies Major Developmental Genes Involved in Shape Determination.

Authors:  Luisa F Pallares; Peter Carbonetto; Shyam Gopalakrishnan; Clarissa C Parker; Cheryl L Ackert-Bicknell; Abraham A Palmer; Diethard Tautz
Journal:  PLoS Genet       Date:  2015-11-02       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.